Saturday, May 03, 2025 3:48:06 PM
I believe the language may very well be speaking of the final tests that must be performed on the EDEN, not the entire testing program. As I understand it, the company has facilities in London, as well as at FlaskWorks, where more preliminary testing could be done.
If I'm right, the inspectors will be inspecting the entire Sawston facility, including multiple operating EDEN units and be certifying that the entire facility is approved after making some number of vials of the vaccine.
Of course I'm only speculating in the same way others would like people to believe that nothing is happening until Sawston is complete. I believe if NWBO wished, they could have EDEN's working in existing cleanrooms at CRL, but of course they'd be paying for the services CRL provided, and they're not intended for UK consumption.
I believe that many things are moving ahead simultaneously, I can't say how close they are to complete, but I believe the company's working on submissions to other regulators, they're working on new trials that will start later this year, and yes work on the EDEN continues. Much of this work is being done by contractors, the point is it continues.
Gary
If I'm right, the inspectors will be inspecting the entire Sawston facility, including multiple operating EDEN units and be certifying that the entire facility is approved after making some number of vials of the vaccine.
Of course I'm only speculating in the same way others would like people to believe that nothing is happening until Sawston is complete. I believe if NWBO wished, they could have EDEN's working in existing cleanrooms at CRL, but of course they'd be paying for the services CRL provided, and they're not intended for UK consumption.
I believe that many things are moving ahead simultaneously, I can't say how close they are to complete, but I believe the company's working on submissions to other regulators, they're working on new trials that will start later this year, and yes work on the EDEN continues. Much of this work is being done by contractors, the point is it continues.
Gary
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
